Last updated on November 2019

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis


Brief description of study

This phase 2b study is designed to evaluate the safety and efficacy of tezepelumab as a monotherapy and explore its efficacy as adjunct therapy in subjects with moderate-to-severe AD.

Detailed Study Description

All subjects will receive a SC dose of either investigational product or placebo as the first dose on day 1.

Subjects who are determined to be non-responders in Part A will receive tezepelumab SC Q2W following completion of all week 16 study activities. Nonresponders are defined as those subjects who have not achieved at least a 50% improvement in EASI at week 16 compared to baseline (day 1).

Safety follow-up is 12 weeks after the EOT visit (14 weeks after the final dose of investigational product).

Clinical Study Identifier: NCT03809663

Find a site near you

Start Over

Research Site

Fountain Valley, CA United States
  Connect »

Research Site

Santa Monica, CA United States
  Connect »

Research Site

Alpharetta, GA United States
  Connect »

Research Site

West Dundee, IL United States
  Connect »

Research Site

New Albany, IN United States
  Connect »

Research Site

Overland Park, KS United States
  Connect »

Research Site

Louisville, KY United States
  Connect »

Research Site

Clarkston, MI United States
  Connect »

Research Site

Henderson, NV United States
  Connect »

Research Site

Stony Brook, NY United States
  Connect »

Research Site

Nashville, TN United States
  Connect »

Research Site

Dallas, TX United States
  Connect »

Research Site

Spokane, WA United States
  Connect »

Research Site

Sydney, Australia
  Connect »

Research Site

Woolloongabba, Australia
  Connect »

Research Site

Carlton, Australia
  Connect »

Research Site

London, ON Canada
  Connect »

Research Site

Mississauga, ON Canada
  Connect »

Research Site

Newmarket, ON Canada
  Connect »

Research Site

Toronto, ON Canada
  Connect »

Research Site

Southampton, United Kingdom
  Connect »

Research Site

Surrey, BC Canada
  Connect »

Research Site

Markham, ON Canada
  Connect »

Research Site

Praha 1, Czechia
  Connect »

Research Site

Sakai-shi, Japan
  Connect »

Research Site

Parkville, Australia
  Connect »

Research Site

Dundee, United Kingdom
  Connect »

Research Site

London, United Kingdom
  Connect »

Research Site

New York, NY United States
  Connect »

Research Site

Ottawa, ON Canada
  Connect »

Research Site

Novy Jicin, Czechia
  Connect »

Research Site

Tallinn, Estonia
  Connect »

Research Site

Ventspils, Latvia
  Connect »

Research Site

Springfield, IL United States
  Connect »

Research Site

Ostrava-Poruba, Czechia
  Connect »

Research Site

Budapest, Hungary
  Connect »

Research Site

Miskolc, Hungary
  Connect »

Research Site

Shinagawa-ku, Japan
  Connect »

Research Site

Barcelona, Spain
  Connect »

Research Site

Fremantle, Australia
  Connect »

Research Site

Warszawa, Poland
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Sapporo-shi, Japan
  Connect »

Research Site

Shinjuku-ku, Japan
  Connect »

Research Site

Takaoka-shi, Japan
  Connect »

Research Site

Bucheon-si, Gyeonggi-do, Korea, Republic of
  Connect »

Research Site

Busan, Korea, Republic of
  Connect »

Research Site

Seoul, Korea, Republic of
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Suwon-si, Gyeonggi-do, Korea, Republic of
  Connect »

Research Site

Chernivtsi, Ukraine
  Connect »

Research Site

Uzhhorod, Ukraine
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Obihiro-shi, Japan
  Connect »

Research Site

Chiyoda-ku, Japan
  Connect »

Research Site

Zaporizhzhia, Ukraine
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Praha 8, Czechia
  Connect »

Research Site

Göttingen, Germany
  Connect »

Research Site

Hannover, Germany
  Connect »

Research Site

Debrecen, Hungary
  Connect »

Research Site

Sakura-shi, Japan
  Connect »

Research Site

Fukuoka-shi, Japan
  Connect »

Research Site

Nishinomiya-shi, Japan
  Connect »

Research Site

Nagasaki-shi, Japan
  Connect »

Research Site

Bunkyo-ku, Japan
  Connect »

Research Site

Ivano-Frankivsk, Ukraine
  Connect »

Research Site

Göttingen, Germany
  Connect »